| Wed, Dec 16, 2009 | | • | Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
PR Newswire (Wed, Dec 16)
| | Fri, Dec 4, 2009 | | • | OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Fri, Dec 4)
| | Thu, Dec 3, 2009 | | • | Optimer Pharmaceuticals Appoints Robert L. Zerbe, M.D. to its Board of Directors
PR Newswire (Thu, Dec 3)
| | Tue, Nov 24, 2009 | | • | Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
PR Newswire (Tue, Nov 24)
| | Thu, Nov 12, 2009 | | • | Optimer Pharma upgraded by Oppenheimer
Briefing.com (Thu, Nov 12)
| | • | Optimer Pharmaceuticals Completes Enrollment in Second Fidaxomicin Phase 3 Clinical Trial in Patients With Clostridium difficile Infection
PR Newswire (Thu, Nov 12)
| | Wed, Nov 11, 2009 | | • | Optimer Beats Estimates
Zacks.com (Wed, Nov 11)
| | Sat, Nov 7, 2009 | | • | OPTIMER PHARMACEUTICALS INC Financials
EDGAR Online Financials (Sat, Nov 7)
| | Wed, Nov 4, 2009 | | • | New Star Analyst Rankings for Optimer Pharmaceuticals, Inc.
StarMine (Wed, Nov 4)
| | Tue, Nov 3, 2009 | | • | OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
EDGAR Online (Tue, Nov 3)
| | • | Optimer Pharmaceuticals Reports Third Quarter 2009 Financial Results
PR Newswire (Tue, Nov 3)
| | Sat, Oct 31, 2009 | | • | Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting
PR Newswire (Sat, Oct 31)
| | Mon, Oct 26, 2009 | | • | Optimer Pharmaceuticals to Present at November 2009 Investor Conferences
PR Newswire (Mon, Oct 26)
| | Fri, Oct 23, 2009 | | • | Biotech Calendar: Key Upcoming Trials
at TheStreet.com (Fri, Oct 23)
| | Tue, Oct 20, 2009 | | • | Galleon's Biotech Stock Holdings: BioBuzz
at TheStreet.com (Tue, Oct 20)
| | • | Biotech Mergers And Acquisitions Will Accelerate According To Wedbush Morgan Expert Analyst As More Expensive Phase III Trials Force Small Biotech Companies Into Large Pharma Distribution And Finance Organizations
Wall Street Transcript (Tue, Oct 20)
| | Mon, Oct 19, 2009 | | • | Optimer Pharmaceuticals Announces Presentations of Additional Data From the Fidaxomicin North American Phase 3 Trial at Upcoming IDSA Annual Meeting
PR Newswire (Mon, Oct 19)
| | Fri, Aug 7, 2009 | | • | OPTIMER PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Aug 7)
| | Wed, Aug 5, 2009 | | • | OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
EDGAR Online (Wed, Aug 5)
| | Mon, May 18, 2009 | | • | Top Takes From RealMoney
at TheStreet.com (Mon, May 18)
|
Add OPTR News to My Yahoo!:
 
| |
|
0.02% Nasdaq 
0.33%
Headlines
